Literature DB >> 1971956

Indomethacin does not antagonize the anxiolytic action of ethanol in the elevated plus-maze.

R L Hale1, A L Johnston, H C Becker.   

Abstract

The present study was designed to examine whether the prostaglandin (PG) synthesis inhibitor indomethacin (INDO) could antagonize the anxiolytic effects of ethanol (EtOH) in the elevated plus-maze test of anxiety. EtOH (1.6 g/kg) significantly increased the percentage of open arm entries and time spent on the open arms in both inbred C57BL/6J and outbred CD-1 mouse strains. However, this anxiolytic effect of EtOH was not significantly antagonized by pretreatment with INDO (5 and 10 mg/kg) in either strain. EtOH also significantly increased total arm entries in CD-1 mice, but not in the C57BL/6J strain. These data from C57BL/6J mice indicate that the low-dose stimulant properties of EtOH can be dissociated from the anxiolytic action of the drug in the plus-maze task. Finally, although INDO did not antagonize the stimulant effect of EtOH in the plus-maze task (in CD-1 mice), it did attenuate EtOH-induced stimulation of locomotor activity in an open-field arena. Taken together, these results suggest some specificity with regard to the role of PGs in mediating (or modulating) the neurobehavioral actions of EtOH, and further support the notion that the anxiolytic and stimulant effects of EtOH may be mediated by different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971956     DOI: 10.1007/bf02244127

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Effects of ethanol and chlordiazepoxide on social interaction in rats [proceedings].

Authors:  S E File; J Hyde; M Pool
Journal:  Br J Pharmacol       Date:  1976-11       Impact factor: 8.739

2.  Interactions of three benzodiazepine receptor inverse agonists with ethanol in a plus-maze test of anxiety.

Authors:  R G Lister
Journal:  Pharmacol Biochem Behav       Date:  1988-07       Impact factor: 3.533

3.  Time course of ethanol's effects on locomotor activity, exploration and anxiety in mice.

Authors:  M J Durcan; R G Lister
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Inhibition of prostaglandin synthesis by indomethacin does not affect alcohol consumption in inbred mice.

Authors:  R F Anton; C L Randall; C K Williams; G E Hoffmeyer
Journal:  Alcohol Clin Exp Res       Date:  1983       Impact factor: 3.455

5.  The use of a plus-maze to measure anxiety in the mouse.

Authors:  R G Lister
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  Prostaglandin synthetase inhibitors antagonize the depressant effects of ethanol.

Authors:  F R George; A C Collins
Journal:  Pharmacol Biochem Behav       Date:  1979-06       Impact factor: 3.533

7.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

8.  Ethanol-induced locomotor stimulation in C57BL/6 mice following RO15-4513 administration.

Authors:  H C Becker; R L Hale
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

9.  Chlordiazepoxide and ethanol additively reduce gustatory negative contrast.

Authors:  H C Becker; C F Flaherty
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Attenuation of the effects of punishment by ethanol: comparisons with chlordiazepoxide.

Authors:  R A Vogel; G D Frye; J H Wilson; C M Kuhn; K M Koepke; R B Mailman; R A Mueller; G R Breese
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  1 in total

1.  Operant, oral alcoholic beer self-administration by C57BL/6J mice: effect of BHF177, a positive allosteric modulator of GABA(B) receptors.

Authors:  Alessandro Orrù; Daniele Fujani; Chiara Cassina; Mirko Conti; Angelo Di Clemente; Luigi Cervo
Journal:  Psychopharmacology (Berl)       Date:  2012-03-13       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.